Medical Devices: Reclassification framework of certain devices
The TGA has commenced the implementation of revised medical device...
Latest Insights
Latest News
Commercial Eyes acquires Open Sesame Consulting
We are excited to announce the acquisition of Open Sesame Consulting by Commercial...
A thriving business in dormant times
We are in the business of assisting clients bring their medicines, medical devices, and diagnostics to the Australian market....
Happy Birthday Commercial Eyes!
In a consulting company, there is no ‘product’ without the people. Without the people, Commercial Eyes Pty Ltd would simply be a ‘legal entity’, without any real function, personality or...
Thanks for giving a country kid a go
A big thank you, John Kennedy, for giving a kid from the country a...
Hand sanitiser – What do you need to know to supply in Australia?
The COVID-19 pandemic has seen the TGA rapidly changing the regulatory landscape for in-demand products that can help reduce the spread of the virus. Given all the changes taking place,...
(NOT) BUSINESS AS USUAL
At Commercial Eyes, we focus our efforts on supporting clients in the regulated therapeutics industry get their products to the patients who need them, when they need...
ARCS Australia appoints Commercial Eyes Founder and Managing Director to Board.
ARCS Australia has appointed Commercial Eyes Founder and Managing Director, Andrew Carter, to its Board of...
Educating and empowering Indigenous children through Yalari
Commercial Eyes is honoured to be able to provide ongoing support to educating Indigenous children through...
Leukaemia Foundation – Raising Awareness of Blood Cancers
Through various parts of our business including market access and insights, regulatory services and medical communications, Commercial Eyes works with a number of organisations involved in improving and extending the...
No CE mark? No problem.
Changes to legislation have increased flexibility for Sponsors looking to market medical devices in...
Are you ready for the mandatory transition to eCTD for prescription medicines?
A staged implementation has been proposed for prescription medicines to reflect the current industry uptake of the eCTD format. The transition begins with new chemical entity, new biological entity, biosimilar...